Tetrahydroisoquinoline derivatives are used as positive D1 activity modulators and in pharmaceutical preparations containing them.
VN10062049BActive Publication Date: 2026-11-02UCB BIOPHARMA SPRL
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- VN1202304651
- Authority / Receiving Office
- VN · VN
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2021-12-16
- Publication Date
- 2026-11-02
- Estimated Expiration
- 2041-12-16
Abstract
The invention relates to a compound according to formula (I), It is a positive modulator of DI activity and is therefore useful as a pharmaceutical agent for treating diseases in which DI receptors play a role.
Need to check novelty before this filing date? Find Prior Art
